Neuroleptic malignant syndrome in a COVID-19 patient.
Identifieur interne : 000F35 ( Main/Exploration ); précédent : 000F34; suivant : 000F36Neuroleptic malignant syndrome in a COVID-19 patient.
Auteurs : Raahil Kajani [États-Unis] ; Austin Apramian [États-Unis] ; Arturo Vega [États-Unis] ; Nitin Ubhayakar [États-Unis] ; Prissilla Xu [États-Unis] ; Antonio Liu [États-Unis]Source :
- Brain, behavior, and immunity [ 1090-2139 ] ; 2020.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen (MeSH), Agonistes de la dopamine (usage thérapeutique), Antienzymes (usage thérapeutique), Atteinte rénale aigüe (thérapie), Atteinte rénale aigüe (étiologie), Betacoronavirus (MeSH), Bromocriptine (usage thérapeutique), Dantrolène (usage thérapeutique), Dialyse rénale (MeSH), Halopéridol (analogues et dérivés), Halopéridol (effets indésirables), Humains (MeSH), Hydroxychloroquine (usage thérapeutique), Hyperleucocytose (MeSH), Infections à coronavirus (complications), Infections à coronavirus (immunologie), Infections à coronavirus (physiopathologie), Infections à coronavirus (thérapie), Lymphopénie (MeSH), Myorelaxants à action centrale (usage thérapeutique), Mâle (MeSH), Neuroleptiques (effets indésirables), Pandémies (MeSH), Pneumopathie virale (complications), Pneumopathie virale (immunologie), Pneumopathie virale (physiopathologie), Pneumopathie virale (thérapie), Protéine C-réactive (immunologie), Rhabdomyolyse (thérapie), Rhabdomyolyse (étiologie), Schizophrénie (complications), Schizophrénie (traitement médicamenteux), Syndrome malin des neuroleptiques (physiopathologie), Syndrome malin des neuroleptiques (thérapie), Syndrome malin des neuroleptiques (étiologie), Unités de soins intensifs (MeSH), Ventilation artificielle (MeSH).
- MESH :
- analogues et dérivés : Halopéridol.
- effets indésirables : Halopéridol, Infections à coronavirus, Neuroleptiques, Pneumopathie virale, Schizophrénie.
- immunologie : Infections à coronavirus, Pneumopathie virale, Protéine C-réactive.
- physiopathologie : Infections à coronavirus, Pneumopathie virale, Syndrome malin des neuroleptiques.
- thérapie : Atteinte rénale aigüe, Infections à coronavirus, Pneumopathie virale, Rhabdomyolyse, Syndrome malin des neuroleptiques.
- traitement médicamenteux : Schizophrénie.
- usage thérapeutique : Agonistes de la dopamine, Antienzymes, Bromocriptine, Dantrolène, Hydroxychloroquine, Myorelaxants à action centrale.
- étiologie : Atteinte rénale aigüe, Rhabdomyolyse, Syndrome malin des neuroleptiques.
- Adulte d'âge moyen, Betacoronavirus, Dialyse rénale, Humains, Hyperleucocytose, Lymphopénie, Mâle, Pandémies, Unités de soins intensifs, Ventilation artificielle.
English descriptors
- KwdEn :
- Acute Kidney Injury (etiology), Acute Kidney Injury (therapy), Antipsychotic Agents (adverse effects), Betacoronavirus (MeSH), Bromocriptine (therapeutic use), C-Reactive Protein (immunology), COVID-19 (MeSH), Coronavirus Infections (complications), Coronavirus Infections (immunology), Coronavirus Infections (physiopathology), Coronavirus Infections (therapy), Dantrolene (therapeutic use), Dopamine Agonists (therapeutic use), Enzyme Inhibitors (therapeutic use), Haloperidol (adverse effects), Haloperidol (analogs & derivatives), Humans (MeSH), Hydroxychloroquine (therapeutic use), Intensive Care Units (MeSH), Leukocytosis (MeSH), Lymphopenia (MeSH), Male (MeSH), Middle Aged (MeSH), Muscle Relaxants, Central (therapeutic use), Neuroleptic Malignant Syndrome (etiology), Neuroleptic Malignant Syndrome (physiopathology), Neuroleptic Malignant Syndrome (therapy), Pandemics (MeSH), Pneumonia, Viral (complications), Pneumonia, Viral (immunology), Pneumonia, Viral (physiopathology), Pneumonia, Viral (therapy), Renal Dialysis (MeSH), Respiration, Artificial (MeSH), Rhabdomyolysis (etiology), Rhabdomyolysis (therapy), SARS-CoV-2 (MeSH), Schizophrenia (complications), Schizophrenia (drug therapy).
- MESH :
- chemical , adverse effects : Antipsychotic Agents, Haloperidol.
- chemical , analogs & derivatives : Haloperidol.
- complications : Coronavirus Infections, Pneumonia, Viral, Schizophrenia.
- drug therapy : Schizophrenia.
- etiology : Acute Kidney Injury, Neuroleptic Malignant Syndrome, Rhabdomyolysis.
- chemical , immunology : C-Reactive Protein, Coronavirus Infections, Pneumonia, Viral.
- physiopathology : Coronavirus Infections, Neuroleptic Malignant Syndrome, Pneumonia, Viral.
- chemical , therapeutic use : Bromocriptine, Dantrolene, Dopamine Agonists, Enzyme Inhibitors, Hydroxychloroquine, Muscle Relaxants, Central.
- therapy : Acute Kidney Injury, Coronavirus Infections, Neuroleptic Malignant Syndrome, Pneumonia, Viral, Rhabdomyolysis.
- Betacoronavirus, COVID-19, Humans, Intensive Care Units, Leukocytosis, Lymphopenia, Male, Middle Aged, Pandemics, Renal Dialysis, Respiration, Artificial, SARS-CoV-2.
DOI: 10.1016/j.bbi.2020.05.042
PubMed: 32425332
PubMed Central: PMC7232071
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Neuroleptic malignant syndrome in a COVID-19 patient.</title>
<author><name sortKey="Kajani, Raahil" sort="Kajani, Raahil" uniqKey="Kajani R" first="Raahil" last="Kajani">Raahil Kajani</name>
<affiliation wicri:level="2"><nlm:affiliation>Adventist Health White Memorial, Los Angeles, CA, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Adventist Health White Memorial, Los Angeles, CA</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Apramian, Austin" sort="Apramian, Austin" uniqKey="Apramian A" first="Austin" last="Apramian">Austin Apramian</name>
<affiliation wicri:level="2"><nlm:affiliation>Adventist Health White Memorial, Los Angeles, CA, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Adventist Health White Memorial, Los Angeles, CA</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Vega, Arturo" sort="Vega, Arturo" uniqKey="Vega A" first="Arturo" last="Vega">Arturo Vega</name>
<affiliation wicri:level="2"><nlm:affiliation>Adventist Health White Memorial, Los Angeles, CA, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Adventist Health White Memorial, Los Angeles, CA</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Ubhayakar, Nitin" sort="Ubhayakar, Nitin" uniqKey="Ubhayakar N" first="Nitin" last="Ubhayakar">Nitin Ubhayakar</name>
<affiliation wicri:level="2"><nlm:affiliation>Adventist Health White Memorial, Los Angeles, CA, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Adventist Health White Memorial, Los Angeles, CA</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Xu, Prissilla" sort="Xu, Prissilla" uniqKey="Xu P" first="Prissilla" last="Xu">Prissilla Xu</name>
<affiliation wicri:level="2"><nlm:affiliation>Adventist Health White Memorial, Los Angeles, CA, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Adventist Health White Memorial, Los Angeles, CA</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Liu, Antonio" sort="Liu, Antonio" uniqKey="Liu A" first="Antonio" last="Liu">Antonio Liu</name>
<affiliation wicri:level="2"><nlm:affiliation>Adventist Health White Memorial, Los Angeles, CA, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Adventist Health White Memorial, Los Angeles, CA</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32425332</idno>
<idno type="pmid">32425332</idno>
<idno type="doi">10.1016/j.bbi.2020.05.042</idno>
<idno type="pmc">PMC7232071</idno>
<idno type="wicri:Area/Main/Corpus">001654</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001654</idno>
<idno type="wicri:Area/Main/Curation">001654</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001654</idno>
<idno type="wicri:Area/Main/Exploration">001654</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Neuroleptic malignant syndrome in a COVID-19 patient.</title>
<author><name sortKey="Kajani, Raahil" sort="Kajani, Raahil" uniqKey="Kajani R" first="Raahil" last="Kajani">Raahil Kajani</name>
<affiliation wicri:level="2"><nlm:affiliation>Adventist Health White Memorial, Los Angeles, CA, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Adventist Health White Memorial, Los Angeles, CA</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Apramian, Austin" sort="Apramian, Austin" uniqKey="Apramian A" first="Austin" last="Apramian">Austin Apramian</name>
<affiliation wicri:level="2"><nlm:affiliation>Adventist Health White Memorial, Los Angeles, CA, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Adventist Health White Memorial, Los Angeles, CA</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Vega, Arturo" sort="Vega, Arturo" uniqKey="Vega A" first="Arturo" last="Vega">Arturo Vega</name>
<affiliation wicri:level="2"><nlm:affiliation>Adventist Health White Memorial, Los Angeles, CA, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Adventist Health White Memorial, Los Angeles, CA</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Ubhayakar, Nitin" sort="Ubhayakar, Nitin" uniqKey="Ubhayakar N" first="Nitin" last="Ubhayakar">Nitin Ubhayakar</name>
<affiliation wicri:level="2"><nlm:affiliation>Adventist Health White Memorial, Los Angeles, CA, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Adventist Health White Memorial, Los Angeles, CA</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Xu, Prissilla" sort="Xu, Prissilla" uniqKey="Xu P" first="Prissilla" last="Xu">Prissilla Xu</name>
<affiliation wicri:level="2"><nlm:affiliation>Adventist Health White Memorial, Los Angeles, CA, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Adventist Health White Memorial, Los Angeles, CA</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Liu, Antonio" sort="Liu, Antonio" uniqKey="Liu A" first="Antonio" last="Liu">Antonio Liu</name>
<affiliation wicri:level="2"><nlm:affiliation>Adventist Health White Memorial, Los Angeles, CA, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Adventist Health White Memorial, Los Angeles, CA</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">Brain, behavior, and immunity</title>
<idno type="eISSN">1090-2139</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Acute Kidney Injury (etiology)</term>
<term>Acute Kidney Injury (therapy)</term>
<term>Antipsychotic Agents (adverse effects)</term>
<term>Betacoronavirus (MeSH)</term>
<term>Bromocriptine (therapeutic use)</term>
<term>C-Reactive Protein (immunology)</term>
<term>COVID-19 (MeSH)</term>
<term>Coronavirus Infections (complications)</term>
<term>Coronavirus Infections (immunology)</term>
<term>Coronavirus Infections (physiopathology)</term>
<term>Coronavirus Infections (therapy)</term>
<term>Dantrolene (therapeutic use)</term>
<term>Dopamine Agonists (therapeutic use)</term>
<term>Enzyme Inhibitors (therapeutic use)</term>
<term>Haloperidol (adverse effects)</term>
<term>Haloperidol (analogs & derivatives)</term>
<term>Humans (MeSH)</term>
<term>Hydroxychloroquine (therapeutic use)</term>
<term>Intensive Care Units (MeSH)</term>
<term>Leukocytosis (MeSH)</term>
<term>Lymphopenia (MeSH)</term>
<term>Male (MeSH)</term>
<term>Middle Aged (MeSH)</term>
<term>Muscle Relaxants, Central (therapeutic use)</term>
<term>Neuroleptic Malignant Syndrome (etiology)</term>
<term>Neuroleptic Malignant Syndrome (physiopathology)</term>
<term>Neuroleptic Malignant Syndrome (therapy)</term>
<term>Pandemics (MeSH)</term>
<term>Pneumonia, Viral (complications)</term>
<term>Pneumonia, Viral (immunology)</term>
<term>Pneumonia, Viral (physiopathology)</term>
<term>Pneumonia, Viral (therapy)</term>
<term>Renal Dialysis (MeSH)</term>
<term>Respiration, Artificial (MeSH)</term>
<term>Rhabdomyolysis (etiology)</term>
<term>Rhabdomyolysis (therapy)</term>
<term>SARS-CoV-2 (MeSH)</term>
<term>Schizophrenia (complications)</term>
<term>Schizophrenia (drug therapy)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen (MeSH)</term>
<term>Agonistes de la dopamine (usage thérapeutique)</term>
<term>Antienzymes (usage thérapeutique)</term>
<term>Atteinte rénale aigüe (thérapie)</term>
<term>Atteinte rénale aigüe (étiologie)</term>
<term>Betacoronavirus (MeSH)</term>
<term>Bromocriptine (usage thérapeutique)</term>
<term>Dantrolène (usage thérapeutique)</term>
<term>Dialyse rénale (MeSH)</term>
<term>Halopéridol (analogues et dérivés)</term>
<term>Halopéridol (effets indésirables)</term>
<term>Humains (MeSH)</term>
<term>Hydroxychloroquine (usage thérapeutique)</term>
<term>Hyperleucocytose (MeSH)</term>
<term>Infections à coronavirus (complications)</term>
<term>Infections à coronavirus (immunologie)</term>
<term>Infections à coronavirus (physiopathologie)</term>
<term>Infections à coronavirus (thérapie)</term>
<term>Lymphopénie (MeSH)</term>
<term>Myorelaxants à action centrale (usage thérapeutique)</term>
<term>Mâle (MeSH)</term>
<term>Neuroleptiques (effets indésirables)</term>
<term>Pandémies (MeSH)</term>
<term>Pneumopathie virale (complications)</term>
<term>Pneumopathie virale (immunologie)</term>
<term>Pneumopathie virale (physiopathologie)</term>
<term>Pneumopathie virale (thérapie)</term>
<term>Protéine C-réactive (immunologie)</term>
<term>Rhabdomyolyse (thérapie)</term>
<term>Rhabdomyolyse (étiologie)</term>
<term>Schizophrénie (complications)</term>
<term>Schizophrénie (traitement médicamenteux)</term>
<term>Syndrome malin des neuroleptiques (physiopathologie)</term>
<term>Syndrome malin des neuroleptiques (thérapie)</term>
<term>Syndrome malin des neuroleptiques (étiologie)</term>
<term>Unités de soins intensifs (MeSH)</term>
<term>Ventilation artificielle (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antipsychotic Agents</term>
<term>Haloperidol</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>Haloperidol</term>
</keywords>
<keywords scheme="MESH" qualifier="analogues et dérivés" xml:lang="fr"><term>Halopéridol</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
<term>Schizophrenia</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Schizophrenia</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Halopéridol</term>
<term>Infections à coronavirus</term>
<term>Neuroleptiques</term>
<term>Pneumopathie virale</term>
<term>Schizophrénie</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Acute Kidney Injury</term>
<term>Neuroleptic Malignant Syndrome</term>
<term>Rhabdomyolysis</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
<term>Protéine C-réactive</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>C-Reactive Protein</term>
<term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr"><term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
<term>Syndrome malin des neuroleptiques</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Coronavirus Infections</term>
<term>Neuroleptic Malignant Syndrome</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Bromocriptine</term>
<term>Dantrolene</term>
<term>Dopamine Agonists</term>
<term>Enzyme Inhibitors</term>
<term>Hydroxychloroquine</term>
<term>Muscle Relaxants, Central</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Acute Kidney Injury</term>
<term>Coronavirus Infections</term>
<term>Neuroleptic Malignant Syndrome</term>
<term>Pneumonia, Viral</term>
<term>Rhabdomyolysis</term>
</keywords>
<keywords scheme="MESH" qualifier="thérapie" xml:lang="fr"><term>Atteinte rénale aigüe</term>
<term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
<term>Rhabdomyolyse</term>
<term>Syndrome malin des neuroleptiques</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Schizophrénie</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Agonistes de la dopamine</term>
<term>Antienzymes</term>
<term>Bromocriptine</term>
<term>Dantrolène</term>
<term>Hydroxychloroquine</term>
<term>Myorelaxants à action centrale</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Atteinte rénale aigüe</term>
<term>Rhabdomyolyse</term>
<term>Syndrome malin des neuroleptiques</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Betacoronavirus</term>
<term>COVID-19</term>
<term>Humans</term>
<term>Intensive Care Units</term>
<term>Leukocytosis</term>
<term>Lymphopenia</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Pandemics</term>
<term>Renal Dialysis</term>
<term>Respiration, Artificial</term>
<term>SARS-CoV-2</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term>
<term>Betacoronavirus</term>
<term>Dialyse rénale</term>
<term>Humains</term>
<term>Hyperleucocytose</term>
<term>Lymphopénie</term>
<term>Mâle</term>
<term>Pandémies</term>
<term>Unités de soins intensifs</term>
<term>Ventilation artificielle</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32425332</PMID>
<DateCompleted><Year>2020</Year>
<Month>08</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised><Year>2021</Year>
<Month>01</Month>
<Day>27</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1090-2139</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>88</Volume>
<PubDate><Year>2020</Year>
<Month>08</Month>
</PubDate>
</JournalIssue>
<Title>Brain, behavior, and immunity</Title>
<ISOAbbreviation>Brain Behav Immun</ISOAbbreviation>
</Journal>
<ArticleTitle>Neuroleptic malignant syndrome in a COVID-19 patient.</ArticleTitle>
<Pagination><MedlinePgn>28-29</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S0889-1591(20)30838-2</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bbi.2020.05.042</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kajani</LastName>
<ForeName>Raahil</ForeName>
<Initials>R</Initials>
<AffiliationInfo><Affiliation>Adventist Health White Memorial, Los Angeles, CA, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Apramian</LastName>
<ForeName>Austin</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Adventist Health White Memorial, Los Angeles, CA, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Vega</LastName>
<ForeName>Arturo</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Adventist Health White Memorial, Los Angeles, CA, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Ubhayakar</LastName>
<ForeName>Nitin</ForeName>
<Initials>N</Initials>
<AffiliationInfo><Affiliation>Adventist Health White Memorial, Los Angeles, CA, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Xu</LastName>
<ForeName>Prissilla</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>Adventist Health White Memorial, Los Angeles, CA, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Liu</LastName>
<ForeName>Antonio</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Adventist Health White Memorial, Los Angeles, CA, United States.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>05</Month>
<Day>18</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Netherlands</Country>
<MedlineTA>Brain Behav Immun</MedlineTA>
<NlmUniqueID>8800478</NlmUniqueID>
<ISSNLinking>0889-1591</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014150">Antipsychotic Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018491">Dopamine Agonists</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004791">Enzyme Inhibitors</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D009125">Muscle Relaxants, Central</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>3A64E3G5ZO</RegistryNumber>
<NameOfSubstance UI="D001971">Bromocriptine</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber>
<NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>9007-41-4</RegistryNumber>
<NameOfSubstance UI="D002097">C-Reactive Protein</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>AC20PJ4101</RegistryNumber>
<NameOfSubstance UI="C033563">haloperidol decanoate</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>F64QU97QCR</RegistryNumber>
<NameOfSubstance UI="D003620">Dantrolene</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>J6292F8L3D</RegistryNumber>
<NameOfSubstance UI="D006220">Haloperidol</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014150" MajorTopicYN="N">Antipsychotic Agents</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001971" MajorTopicYN="N">Bromocriptine</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002097" MajorTopicYN="N">C-Reactive Protein</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003620" MajorTopicYN="N">Dantrolene</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018491" MajorTopicYN="N">Dopamine Agonists</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004791" MajorTopicYN="N">Enzyme Inhibitors</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006220" MajorTopicYN="N">Haloperidol</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
<QualifierName UI="Q000031" MajorTopicYN="Y">analogs & derivatives</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007964" MajorTopicYN="N">Leukocytosis</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008231" MajorTopicYN="N">Lymphopenia</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009125" MajorTopicYN="N">Muscle Relaxants, Central</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009459" MajorTopicYN="N">Neuroleptic Malignant Syndrome</DescriptorName>
<QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006435" MajorTopicYN="N">Renal Dialysis</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012206" MajorTopicYN="N">Rhabdomyolysis</DescriptorName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012559" MajorTopicYN="N">Schizophrenia</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>05</Month>
<Day>06</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2020</Year>
<Month>05</Month>
<Day>14</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>05</Month>
<Day>14</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>5</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>8</Month>
<Day>15</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>5</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32425332</ArticleId>
<ArticleId IdType="doi">10.1016/j.bbi.2020.05.042</ArticleId>
<ArticleId IdType="pii">S0889-1591(20)30838-2</ArticleId>
<ArticleId IdType="pmc">PMC7232071</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Californie</li>
</region>
</list>
<tree><country name="États-Unis"><region name="Californie"><name sortKey="Kajani, Raahil" sort="Kajani, Raahil" uniqKey="Kajani R" first="Raahil" last="Kajani">Raahil Kajani</name>
</region>
<name sortKey="Apramian, Austin" sort="Apramian, Austin" uniqKey="Apramian A" first="Austin" last="Apramian">Austin Apramian</name>
<name sortKey="Liu, Antonio" sort="Liu, Antonio" uniqKey="Liu A" first="Antonio" last="Liu">Antonio Liu</name>
<name sortKey="Ubhayakar, Nitin" sort="Ubhayakar, Nitin" uniqKey="Ubhayakar N" first="Nitin" last="Ubhayakar">Nitin Ubhayakar</name>
<name sortKey="Vega, Arturo" sort="Vega, Arturo" uniqKey="Vega A" first="Arturo" last="Vega">Arturo Vega</name>
<name sortKey="Xu, Prissilla" sort="Xu, Prissilla" uniqKey="Xu P" first="Prissilla" last="Xu">Prissilla Xu</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000F35 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000F35 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= CovidChloroV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:32425332 |texte= Neuroleptic malignant syndrome in a COVID-19 patient. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32425332" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a CovidChloroV1
![]() | This area was generated with Dilib version V0.6.38. | ![]() |